(1r)-1-(1-Benzofuran-2-yl)ethan-1-ol, 95%, 250mg

1,4-Dioxane, min. 99.5%, for synthesis, stabilized, 2.5 l, glass packaging

2-Bromo-3-ethylthiophene, 98%, 25g

5-CHLOROMETHYL-3-CYCLOBUTYL-[1,2,4]OXADIAZOLE, 95.0%, 250mg

Guanethidine Monosulfate>97.0%(T)250mg

2-Methyl-4H-chromen-4-one, 95%, 5g

2-Bromo-6-chloro-4-(trifluoromethoxy)aniline, 95.0%, 5g

2-(Trimethylsilyl)ethyl 3-nitro-1H-1,2,4-triazole-1-carboxylate, 97%, 100mg

4-N-CBZ-AMINO-BUTAN-1-OL, 97.0%, 1g

Palonosetron Hydrochloride>98.0%(HPLC)(T)200mg

Dimethyl(n-octyl)(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research]>98.0%(HPLC)(N)5g

tert-Butyl (1R*,4R*)-4-(isonicotinamido)cyclohexylcarbamate, 1g

Boc-D-Glu-OBzl, 98%, 10g